Main menu button

News

Mrkt Buzz DanCann Pharma: Crucial approval reduces a layer of risk
07 Dec 2022
Mrkt Buzz DanCann Pharma: Crucial approval reduces a layer of risk
Equity Research DanCann Pharma
Research Update DanCann Pharma, Q3 2022: New agreement boosts prospects
07 Nov 2022
Research Update DanCann Pharma, Q3 2022: New agreement boosts prospects
Equity Research DanCann Pharma
Research Update DanCann Pharma, Q2 2022: Rights issue to reach break-even
05 Sep 2022
Research Update DanCann Pharma, Q2 2022: Rights issue to reach break-even
Equity Research DanCann Pharma
Research Update DanCann Pharma, Q1 2022: Building pipeline ahead of launch
08 Jun 2022
Research Update DanCann Pharma, Q1 2022: Building pipeline ahead of launch
Equity Research DanCann Pharma
Mrkt BUZZ DanCann Pharma: Strengthens future pipeline by at least SEK 37 million
15 May 2022
Mrkt BUZZ DanCann Pharma: Strengthens future pipeline by at least SEK 37 million
Equity Research DanCann Pharma
Research update DanCann Pharma Q4 2021: The start of a new era?
24 Mar 2022
Research update DanCann Pharma Q4 2021: The start of a new era?
Equity Research DanCann Pharma
Research update DanCann, Q3 2021: Brighter outlook than ever before
07 Dec 2021
Research update DanCann, Q3 2021: Brighter outlook than ever before
Equity Research DanCann Pharma
Research update, DanCann Pharma Q2 2021: Transformative acquisition adds great value
12 Oct 2021
Research update, DanCann Pharma Q2 2021: Transformative acquisition adds great value
Equity Research DanCann Pharma
Equity Research, DanCann Pharma Q1 2021: Good news flow increases fair value
03 Jun 2021
Equity Research, DanCann Pharma Q1 2021: Good news flow increases fair value
Equity Research DanCann Pharma